/ Source_Taiwan Academy of Tumor Ablation

As research on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and liver cancer continues to advance rapidly, the integration of artificial intelligence (AI) is bringing revolutionary breakthroughs in clinical prediction and precision medicine.
The 2026 Joint International Symposium on Liver Cancer and Fatty Liver Disease, hosted by the Center for Digestive Medicine Research at Taipei Medical University, brings together leading scholars and clinical experts from Taiwan and around the world for comprehensive and in-depth discussions on AI-powered precision medicine, keynote lectures, and the latest advances in basic research. We sincerely invite you to join us for this exciting academic event!

※No registration is required.※

Event Title: Joint International Symposium on Liver Cancer and Fatty Liver Disease, Center for Digestive Medicine Research, Taipei Medical University
Time: August 8, 2026 (Saturday), 1:30 PM–5:30 PM
Venue: 4F. Exhibition and Performance Hall, Xing-Chun Building, Taipei Medical University → No. 250, Wuxing St., Xinyi Dist., Taipei City, Taiwan
Organizer: TMU Research Center for Digestive Medicine (TMU RCDM)
Co-organizers / Supporting Organizations: 
 - Taipei Cancer Center
 - Fatty Liver Group, Research Center for Digestive Medicine Research, Taipei Medical University
 - Department of Research, Taipei Medical University Hospital
Continuing Education Credits: 4 credits in Category B from Taiwan Academy of Tumor Ablation
Event Website: https://reurl.cc/gN0jAQ 
Contact: Mr. Lin (895034@h.tmu.edu.tw) / +886-2-2737-2181 ext. 3577